Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems (Q34285667)

1 August 2017

1 reference

title

Formulation and physiological and biopharmaceutical issues in the development of oral lipid-based drug delivery systems (English)

1 reference

1 August 2017

1 reference

Wasan KM

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Drug Development and Industrial Pharmacy

1 August 2017

published in

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

267-276

1 reference

Effect of dietary lipids on hepatic and intestinal monooxygenases in mice

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Effect of high fat diet on liver microsomal oxygenations in ferret

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Optimizing the absorption of valspodar, a P-glycoprotein modulator, Part I: Selecting an oral formulation and exploring its clinical pharmacokinetics/dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Effect of oily vehicles on absorption of mepitiostane by the lymphatic system in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Intrinsic lymphatic partition rate of mepitiostane, epitiostanol, and oleic acid absorbed from rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Mechanisms of altered sequestration and efflux of chemotherapeutic drugs by multidrug-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Modulation of the levels of cytochromes P450 in rat liver and lung by dietary lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Dietary fats and properties of endoplasmic reticulum: II. Dietary lipid induced changes in activities of drug metabolizing enzymes in liver and duodenum of rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

The composition and structure of lymph chylomicrons in dog, rat, and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Partitioning of polar fatty acids into lymph and portal vein after intestinal absorption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

In vitro--in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-100103726

21 January 2018

Identifiers

DOI

10.1081/DDC-100103726

1 reference

1 August 2017

1 reference